Niemann-Pick type C (NP-C) is a rare recessive disorder associated with progressive supranuclear gaze palsy. Degeneration occurs initially for vertical saccades and later for horizontal saccades. There are studies of oculomotor degeneration in adult NP-C patients [1, 2] but no comparable studies in children. We used high-resolution video-based eye tracking to record monocular vertical and horizontal eye movements in 2 neurological NP-C patients (children with clinically observable oculomotor abnormalities) and 3 pre-neurological NP-C patients (children without clinically observable oculomotor abnormalities). Saccade onset latency, saccade peak velocity and saccade curvature were compared to healthy controls (N=77). NP-C patients had selective impairments of vertical saccade peak velocity and vertical saccade curvature, with slower peak velocities and greater curvature. Changes were more pronounced in neurological than pre-neurological patients, showing that these measures are sensitive to disease progress, but abnormal curvature and slowed downward saccades were present in both groups, showing that eye-tracking can register disease-related changes before these are evident in a clinical exam. Both slowing, curvature and the detailed characteristics of the curvature we observed are predicted by the detailed characteristics of RIMLF population codes. Onset latencies were not different from healthy controls. High-resolution video-based eye tracking is a promising sensitive and objective method to measure NP-C disease severity and neurological onset. It may also help evaluate responses to therapeutic interventions.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymgme.2017.11.004DOI Listing

Publication Analysis

Top Keywords

np-c patients
16
oculomotor abnormalities
12
niemann-pick type
8
high-resolution video-based
8
video-based eye
8
eye tracking
8
patients children
8
children clinically
8
clinically observable
8
observable oculomotor
8

Similar Publications

The multisystemic effects of COVID-19 may continue for a longer time period following the acute phase, depending on the severity of the disease. However, long-term systemic transcriptomic changes associated with COVID-19 disease and the impact of disease severity are not fully understood. We aimed to investigate the impact of COVID-19 and its severity on transcriptomic alterations in peripheral blood mononuclear cells (PBMCs) following 1 year of the disease.

View Article and Find Full Text PDF

Building Clinical Care Capacity for Patients With Special Pathogens in Advance of the Next Outbreak.

Health Secur

September 2024

Lauren Wiesner, MD, is Chair, Department of Emergency Medicine; Aaron Resnick, MA, is Program Director, Biocontainment Unit; Bethany Little, BSN, RN, NHDP-BC, is Nursing Operations Director and Training and Education Coordinator, Biocontainment Unit; Glenn Wortmann, MD, is Section Director, Infectious Diseases; Craig DeAtley, PA-C, is Director, Institute for Public Health Emergency Readiness; and Shane B. Kappler, MD, MS, FACEP, is Medical Director, Biocontainment Unit; all at MedStar Washington Hospital Center, Washington, DC. Lauren Wiesner is also an Associate Professor of Emergency Medicine; Glenn Wortmann is also a Professor of Clinical Medicine (Infectious Diseases); and Shane B. Kappler is also an Assistant Professor of Emergency Medicine and Microbiology and Immunology; all at Georgetown University School of Medicine, Washington, DC. Jade Flinn, MSN, RN, CCRN, CNRN, is Director of Operations, Johns Hopkins Special Pathogens Center, and Brian T. Garibaldi, MD, MEHP, FACP, FRCP(E), was Director, Johns Hopkins Special Pathogens Center, and Director, Johns Hopkins Biocontainment Unit; all at The Johns Hopkins Hospital, Baltimore, MD. Brooke Brewer, RN, MS, CIC, is Program Manager, Infection Prevention; Natalie A. Schnell, BSN, RN, R-BC, CIC, is an Infection Prevention Nurse Educator; and David A. Wohl, MD, and William A. Fischer II, MD, are Co-Directors; all at the Special Pathogen Response Center, Region 4 Emerging Special Pathogen Treatment Center, University of North Carolina Hospitals, Chapel Hill, NC. William A. Fischer II is also Director of Emerging Pathogens, Institute for Global Health and Infectious Diseases, The University of North Carolina at Chapel Hill, Chapel Hill, NC. Sharon Vanairsdale Carrasco, DNP, APRN, ACNS-BC, NP-C, CEN, FAEN, FAAN, is an Associate Professor, Nell Hodgson Woodruff School of Nursing, Emory University, and Program Director, Region 4 Ebola and Other Special Pathogens Treatment Center, Emory University Hospital/Children's Healthcare of Atlanta; both in Atlanta, GA.

In response to the growing number of outbreaks of emerging infectious diseases, the US Administration for Strategic Preparedness and Response (ASPR) has embarked on a plan to improve and expand special pathogen patient care capabilities. To achieve this, ASPR is developing a coordinated network of Regional Emerging Special Pathogen Treatment Centers (RESPTCs) to serve as state-of-the-art facilities staffed by a highly trained workforce to care for and manage special pathogen patients across the lifespan. The RESPTC network represents the operational arm of a broader US National Special Pathogen System of care to prevent and prepare for the next infectious disease outbreak.

View Article and Find Full Text PDF

High-Level Isolation: A Landscape Analysis of Global Capabilities and Opportunities to Advance the Field.

Health Secur

September 2024

Lauren M. Sauer, MSc, is Associate Director of Research, Global Center for Health Security, Director, Special Pathogens Research Network, and Associate Professor, Department of Environmental, Agricultural and Occupational Health, College of Public Health; all at the University of Nebraska Medical Center, Omaha, NE.

High-level isolation units (HLIUs) have been established by countries to provide safe and optimal medical care for patients with high-consequence infectious diseases. We aimed to identify global high-level isolation capabilities and determine gaps and priorities of global HLIUs, using a multiple method approach that included a systematic review of published and gray literature and a review of Joint External Evaluations and Global Health Security Index reports from 112 countries. A follow-up electronic survey was distributed to identified HLIUs.

View Article and Find Full Text PDF

Spread the Word: No Amount of Alcohol is Safe!

Gastroenterol Nurs

August 2024

Linda Morrow, DNP, MSN, MBA, NE-BC, CPHQ, CNOR, RN, is a Program Director, Nursing Management and Executive Leadership, Clinical Associate Professor of Nursing, Dr. Susan L. Davis & Richard J. Henley College of Nursing, Sacred Heart University, Fairfield, Connecticut.

Article Synopsis
  • Excessive alcohol use is widespread in the U.S. and linked to serious health risks, with studies showing no safe level of consumption.
  • The American Cancer Society now advises against drinking alcohol as part of cancer prevention guidelines.
  • Increased awareness and policy changes, such as higher taxes on alcohol and restrictions on advertising, are needed to address the health hazards of alcohol, and gastroenterology nurses play a key role in patient intervention.
View Article and Find Full Text PDF

Introduction: Deceleration of vertical saccades, an early and characteristic finding of Niemann-Pick Type C (NP-C), may help diagnosis. Our aim in this study was to demonstrate the role of video-oculography (VOG), in the differential diagnosis of ataxia syndromes, particularly of NP-C, using this technique in the evaluation of saccadic velocity and smooth pursuit gain of ataxia patients.

Methods: We recruited consecutive 50 ataxia patients and 50 healthy control subjects who were age and sex-matched with the patient group.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!